Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vincent Rajkumar

Blood

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Blood|August 25, 2012
Second to noneS Vincent Rajkumar
Blood|April 11, 2015
Macro-questS Vincent Rajkumar
Blood|November 30, 2017
How I manage monoclonal gammopathy of undetermined significanceRonald S Go, S Vincent Rajkumar
Blood|October 16, 2016
Next-generation multiple myeloma treatment: a pharmacoeconomic perspectiveS Vincent Rajkumar, Jean Luc Harousseau
Blood|March 12, 2008
Multiple myelomaRobert A Kyle, S Vincent Rajkumar
Blood|April 4, 2015
Smoldering multiple myelomaS Vincent Rajkumar, Ola Landgren, María-Victoria Mateos
Blood|July 28, 2011
Approach to the treatment of multiple myeloma: a clash of philosophiesS Vincent Rajkumar, Gösta Gahrton, P Leif Bergsagel
Blood|December 28, 2018
Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timingShaji K Kumar, Francis K Buadi, S Vincent Rajkumar
Blood|February 23, 2012
Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristicsAlexandra J Greenberg, S Vincent Rajkumar, Celine M Vachon
Blood|July 14, 2011
Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survivalJeremy T Larsen, Cheng E Chee, John A Lust, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Blood|August 25, 2012
Second to noneS Vincent Rajkumar
Blood|April 11, 2015
Macro-questS Vincent Rajkumar
Blood|November 30, 2017
How I manage monoclonal gammopathy of undetermined significanceRonald S Go, S Vincent Rajkumar
Blood|October 16, 2016
Next-generation multiple myeloma treatment: a pharmacoeconomic perspectiveS Vincent Rajkumar, Jean Luc Harousseau
Blood|March 12, 2008
Multiple myelomaRobert A Kyle, S Vincent Rajkumar
Blood|April 4, 2015
Smoldering multiple myelomaS Vincent Rajkumar, Ola Landgren, María-Victoria Mateos
Blood|July 28, 2011
Approach to the treatment of multiple myeloma: a clash of philosophiesS Vincent Rajkumar, Gösta Gahrton, P Leif Bergsagel
Blood|December 28, 2018
Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timingShaji K Kumar, Francis K Buadi, S Vincent Rajkumar
Blood|February 23, 2012
Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristicsAlexandra J Greenberg, S Vincent Rajkumar, Celine M Vachon
Blood|July 14, 2011
Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survivalJeremy T Larsen, Cheng E Chee, John A Lust, et al.
Pageof 9